Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Agenus Inc
(NQ:
AGEN
)
5.100
-0.380 (-6.93%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Agenus Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GitLab, Agenus, ZoomInfo, and Super Micro and Encourages Investors to Contact the Firm
Today 21:00 EDT
From
Bragar Eagel & Squire
Via
GlobeNewswire
Agenus Inc. Class Action Reminder - AGEN Stockholders with Large Losses They Should Contact Shareholder Rights Law Firm Robbins LLP for Information About the Agenus Inc. Class Action Lawsuit
September 30, 2024
From
Robbins LLP
Via
GlobeNewswire
AGENUS INC. (NASDAQ: AGEN) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Agenus Inc. Investors of Upcoming Deadline
September 30, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Agenus, and New Fortress and Encourages Investors to Contact the Firm
September 26, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Shareholder Rights Law Firm Robbins LLP Reminds AGEN Stockholders with Large Losses They Should Obtain Counsel to Seek Lead Plaintiff Status in the Agenus Inc. Class Action Lawsuit
September 25, 2024
From
Robbins LLP
Via
Business Wire
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGEN
September 23, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
AGENUS INC. (NASDAQ: AGEN) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Agenus Inc. Investors of Upcoming Deadline
September 23, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GitLab, Agenus, New Fortress, and ZoomInfo and Encourages Investors to Contact the Firm
September 22, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
AGEN Class Action Notice: Robbins LLP Reminds Agenus Inc. Stockholders of Pending AGEN Class Action Lawsuit
September 20, 2024
From
Robbins LLP
Via
GlobeNewswire
AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
September 20, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGEN
September 20, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GitLab, Agenus, and ZoomInfo and Encourages Investors to Contact the Firm
September 18, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
September 18, 2024
GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The study showed a non-inferior immune response and good safety profiles. The...
Via
Benzinga
Exposures
Product Safety
Agenus Inc. Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the AGEN Class Action Lawsuit
September 17, 2024
From
Robbins LLP
Via
Business Wire
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGEN
September 16, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
AGENUS INC. (NASDAQ: AGEN) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Agenus Inc. Investors of Upcoming Deadline
September 16, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GitLab, Agenus, and ZoomInfo and Encourages Investors to Contact the Firm
September 14, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Botensilimab/Balstilimab Clinical Responses in Refractory Sarcomas Presented at ESMO 2024
September 13, 2024
From
Agenus Inc.
Via
Business Wire
AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
September 12, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
AGENUS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Agenus Inc. and Encourages Investors to Contact the Firm
September 11, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Agenus Inc.
September 10, 2024
From
Robbins LLP
Via
GlobeNewswire
AGEN Investors Have Opportunity to Lead Agenus Inc. Securities Fraud Lawsuit with the Schall Law Firm
September 09, 2024
From
The Schall Law Firm
Via
Business Wire
Rosen Law Firm Urges Agenus Inc. (NASDAQ: AGEN) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
September 09, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
AGENUS INC. (NASDAQ: AGEN) INVESTOR ALERT: Investors With Large Losses in Agenus Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
September 09, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Botensilimab/Balstilimab Clinical Activity in Refractory Sarcomas to be Presented in Oral Session at ESMO 2024
September 09, 2024
From
Agenus Inc.
Via
Business Wire
Agenus to Participate in September Investor Conferences
September 03, 2024
From
Agenus Inc.
Via
Business Wire
Agenus (AGEN) Q2 2024 Earnings Call Transcript
August 08, 2024
AGEN earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
AGEN Stock Earnings: Agenus Misses EPS, Misses Revenue for Q2 2024
August 08, 2024
AGEN stock results show that Agenus missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Agenus Reports Second Quarter 2024 Operational and Financial Results
August 08, 2024
From
Agenus Inc.
Via
Business Wire
Agenus Announces Appointment of Tom Harrison to Board of Directors
August 08, 2024
From
Agenus Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.